Corvus Pharma Stock (NASDAQ: CRVS) stock price, news, charts, stock research, profile.
You can purchase shares of Corvus Pharma (NASDAQ:CRVS) through any online brokerage.
Other companies in Corvus Pharma’s space includes: Valneva (NASDAQ:VALN), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO) and Tango Therapeutics (NASDAQ:TNGX).
Corvus Pharma has a consensus price target of $10.60.
The stock price for Corvus Pharma (NASDAQ: CRVS) is $4.9001 last updated January 21, 2025 at 5:24 PM EST.
There are no upcoming dividends for Corvus Pharma.
Corvus Pharma’s Q4 earnings are confirmed for Tuesday, March 18, 2025.
There is no upcoming split for Corvus Pharma.
Corvus Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.